Fecal Pancreatic Elastase by Bioserv Diagnostic
The Fecal Pancreatic Elastase test is an in vitro test kit for the quantitative detection of human pancreatic elastase in stool. It is an FDA registered product (Registration number: 3003594692).
This test is used for the diagnosis of pancreatic insufficiency which may be caused by a number of ailments ranging from autoimmunologically caused pancreatitis to Shwachman Syndrome.
Test Mechanics: Sandwhich Elisa with polyclonal antibodies directed against defined sequences of human pancreatic elastase.
Sample Medium: Stool
Advantages of determining fecal pancreatic elastase:
- Fecal pancreatic elastase is exclusively produced in the pancreas and therefore suitable to diagnosing pancreatic malfunctions like pancreatic insufficiency
- Fecal pancreatic elastase is extraordinarily stable when passing through the bowels
- Pancreatic juice has a concentration of duodenal juices that is 5-6 times higher than in feces
- There is a direct correlation of fecal pancreatic elastase concentration and pancreatic function
- No age-dependency of the fecal pancreatic elastase secretion from infancy (first year) on
- The fecal pancreatic elastase molecule is stable for at least 6 days at refrigeration and for at least 3 days at room temperature
The Bioserv® Elastase ELISA for the detection of fecal pancreatic elastase allows a highly sensitive and specific determination of fecal pancreatic Elastase, enabling the clinician to establish a prompt and reliable diagnosis of suspected cases of pancreatic insufficiency.